Last 497.50 GBp
Change Today -2.50 / -0.50%
Volume 1.3K
IVO On Other Exchanges
Symbol
Exchange
London
Berlin
As of 7:35 AM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Nigel Aaron Pitchford B.Sc., Ph.D., MBA

Chief Investment Officer, Director and Member of Investment Committee, Imperial Innovations Group plc
AgeTotal Calculated CompensationThis person is connected to 57 board members in 5 different organizations across 13 different industries.

See Board Relationships
44371,000 GBP
As of Fiscal Year 2014

Background*

Dr. Nigel Aaron Pitchford, B.Sc., Ph.D., MBA, has been Chief Investment Officer and Director of Imperial Innovations Group plc since October 16, 2013. Dr. Pitchford joined Imperial Innovations Group plc in January 2012. He is responsible for the Group’s investment activities. He served as Managing Director of Healthcare Investments at Imperial Innovations Group plc from January 4, 2012 to October 16, 2013. Dr. Pitchford serves as Partner of Encore Ventures. He was an ...

Read Full Background

Corporate Headquarters*

52 Princes Gate
London, Greater London SW7 2PG

United Kingdom

Phone: 44 20 7581 4949
Fax: 44 20 7594 6584

Board Members Memberships*

Former Non Executive Director
Non-Executive Director
Non Executive Director
Former Investor Director and Director
Former Director
Non-Executive Director
Former Director
Director
2012-Present
Director, Member of Remuneration Committee and Member of Nominating & Corporate Governance Committee
2012-N/A
Director and Member of Remuneration Committee
2013-Present
Chief Investment Officer, Director and Member of Investment Committee

Education*

Unknown/Other Education
University of Oxford
MA
University of Oxford
Doctorate
Durham University
PhD
Durham University
BS
Warwick Business School
MBA
Warwick Business School

Other Affiliations*

Annual Compensation*

Salary186,000 GBP
Bonus166,000 GBP
Total Annual Compensation352,000 GBP

Stock Options*

All Other Compensation19,000 GBP
Unexercisable Options257,142
Unexercisable Options Value244,285 GBP
Total Value of Options244,284 GBP
Total Number of Options257,142

Total Compensation*

Total Annual Cash Compensation371,000 GBP
Total Short Term Compensation352,000 GBP
Other Long Term Compensation19,000 GBP
Total Calculated Compensation371,000 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IVO:LN 497.50 GBp -2.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James T. LaFrance Chairman, Chief Executive Officer and President
Vermillion, Inc.
--
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
$997.0K
Kevin Kowbell Chairman and Interim Chief Executive Officer
Health Discovery Corporation
--
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
C$247.9K
Jan Groen Ph.D.Chief Executive Officer and Executive Director
MDxHealth SA
€470.7K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPERIAL INNOVATIONS GROUP P, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.